HOUSTON,Texas, March 2, 2020 – InformAI is pleased to welcome Innovation Lead Dr. Anil Shetty. As an inventive physician, scientist and entrepreneur with over 20 years of experience in academia and the medical device industry, Dr. Shetty is passionate about purpose-driven innovation and commercialization of disruptive innovative solutions for the health care industry. He has vast experience in multiple sectors, including clinical application development, clinical operations, business development and regulatory planning.
Shetty was a member of the Visualase executive team which led the Houston-based medical startup to a $110 million Medtronic acquisition in five years. Shetty has also led development of applications for epilepsy, spinal tumors, radiation necrosis and prostate tumors which have a combined market size of $ 2.25 billion. Later, he developed a network of clinics offering high resolution MRI, targeted biopsy and focal therapy for prostate cancer. He has a fellowship from MD Anderson Cancer Center and a Biomedical Engineering degree from Texas A&M. He has co-authored 30+peer-reviewed publications in oncology, radiology, neurology and neurosurgery.
InformAI, a healthcare analytics company, builds diagnostic-assist AI tools to change medicine at the point-of-care. The company’s medical image classifiers are built for both 2D and3D MRI/CT/US imaging modalities, and InformAI’s patient risk predictors assist in the detection of targeted medical conditions. Together with their partners,InformAI focuses on high-impact, high-volume solutions in the world’s largest medical center, the Texas Medical Center. The company has assembled some of the largest patient datasets in the industry for AI model training development, and is a technology partner with the NVIDIA Inception Program, Amazon AWS and Microsoft Azure.
To learn more, visit InformAI.com
Press and Investor Relations